- Home
- EVGOW vs VCEL Comparison
EVGOW vs VCEL Comparison
Compare EVGOW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGOW
- VCEL
- Stock Information
- Founded
- EVGOW 2010
- VCEL 1989
- Country
- EVGOW United States
- VCEL United States
- Employees
- EVGOW 331
- VCEL N/A
- Industry
- EVGOW Other Specialty Stores
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVGOW Consumer Discretionary
- VCEL Health Care
- Exchange
- EVGOW Nasdaq
- VCEL Nasdaq
- Market Cap
- EVGOW N/A
- VCEL 2.1B
- IPO Year
- EVGOW N/A
- VCEL 1997
- Fundamental
- Price
- EVGOW $0.19
- VCEL $31.85
- Analyst Decision
- EVGOW
- VCEL Strong Buy
- Analyst Count
- EVGOW 0
- VCEL 6
- Target Price
- EVGOW N/A
- VCEL $60.60
- AVG Volume (30 Days)
- EVGOW 74.7K
- VCEL 823.8K
- Earning Date
- EVGOW 03-07-2025
- VCEL 11-06-2025
- Dividend Yield
- EVGOW N/A
- VCEL N/A
- EPS Growth
- EVGOW N/A
- VCEL 2045.40
- EPS
- EVGOW N/A
- VCEL 0.13
- Revenue
- EVGOW $239,306,000.00
- VCEL $249,119,000.00
- Revenue This Year
- EVGOW N/A
- VCEL $18.35
- Revenue Next Year
- EVGOW N/A
- VCEL $22.47
- P/E Ratio
- EVGOW N/A
- VCEL $236.01
- Revenue Growth
- EVGOW 73.08
- VCEL 16.13
- 52 Week Low
- EVGOW $0.12
- VCEL $29.93
- 52 Week High
- EVGOW $1.99
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- EVGOW 61.36
- VCEL 42.72
- Support Level
- EVGOW $0.15
- VCEL $29.93
- Resistance Level
- EVGOW $0.18
- VCEL $33.25
- Average True Range (ATR)
- EVGOW 0.02
- VCEL 1.75
- MACD
- EVGOW 0.00
- VCEL -0.14
- Stochastic Oscillator
- EVGOW 89.11
- VCEL 27.91
About EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.